These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 15565348
1. Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic sclerosis. Skretkowicz K, Skretkowicz J, Gawrońska-Szklarz B, Górnik W, Rychlik-Sych M, Sysa-Jedrzejowska A. Eur J Clin Pharmacol; 2005 Jan; 60(11):773-8. PubMed ID: 15565348 [Abstract] [Full Text] [Related]
2. N-acetyltransferase 2 acetylation polymorphism: prevalence of slow acetylators does not differ between atopic dermatitis patients and healthy subjects. Brocvielle H, Muret P, Goydadin AC, Boone P, Broly F, Kantelip JP, Humbert P. Skin Pharmacol Appl Skin Physiol; 2003 Jan; 16(6):386-92. PubMed ID: 14528063 [Abstract] [Full Text] [Related]
3. N-acetyltransferase 2 (NAT2) polymorphism in patients with atopic asthma. Pawlik A, Juzyszyn Z, Gawronska-Szklarz B. Arch Med Res; 2009 May; 40(4):264-7. PubMed ID: 19608015 [Abstract] [Full Text] [Related]
5. Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators. Al-Ahmad MM, Amir N, Dhanasekaran S, John A, Abdulrazzaq YM, Ali BR, Bastaki S. Ann Hum Genet; 2017 Sep; 81(5):190-196. PubMed ID: 28653770 [Abstract] [Full Text] [Related]
7. Increased genotype frequency of N-acetyltransferase 2 slow acetylation in patients with rheumatoid arthritis. Pawlik A, Ostanek L, Brzosko I, Gawroska-Szklarz B, Brzosko M, Dabrowska-Zamojcin E. Clin Pharmacol Ther; 2002 Sep; 72(3):319-25. PubMed ID: 12235453 [Abstract] [Full Text] [Related]
8. Genetic analysis of the arylamine N-acetyltransferase polymorphism in breast cancer patients. Agúndez JA, Ladero JM, Olivera M, Abildúa R, Román JM, Benítez J. Oncology; 1995 Sep; 52(1):7-11. PubMed ID: 7800347 [Abstract] [Full Text] [Related]
9. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis. Ben Mahmoud L, Ghozzi H, Kamoun A, Hakim A, Hachicha H, Hammami S, Sahnoun Z, Zalila N, Makni H, Zeghal K. Pathol Biol (Paris); 2012 Oct; 60(5):324-30. PubMed ID: 21856096 [Abstract] [Full Text] [Related]
10. Arylamine N-acetyltransferase-2 genotypes in the Thai population. Kukongviriyapan V, Prawan A, Tassaneyakul W, Aiemsa-Ard J, Warasiha B. Br J Clin Pharmacol; 2003 Mar; 55(3):278-81. PubMed ID: 12630978 [Abstract] [Full Text] [Related]
15. N-acetyltransferase-2 genotypes among Jordanian patients with diabetes mellitus. Irshaid YM, Abujbara MA, Ajlouni KM, El-Khateeb M, Jarrar YB. Int J Clin Pharmacol Ther; 2013 Jul; 51(7):593-9. PubMed ID: 23587153 [Abstract] [Full Text] [Related]
16. [Comparative analysis of N-acetylation polymorphism in humans as determined by phenotyping and genotyping]. Goldenkova-Pavlova IV, Bruskin SA, Abdeev RM, Markarova EV, Bigvava SG, Radkevich LA, Kozhekbaeva ZhM, Glotov AS, Gra OA, Zasedatelev AS, Nasedkina TV, Kurdanov KhA, Piruzian ES. Genetika; 2006 Aug; 42(8):1143-50. PubMed ID: 17025166 [Abstract] [Full Text] [Related]
17. N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men. Hamasaki T, Inatomi H, Katoh T, Aono H, Ikuyama T, Muratani T, Matsumoto T. Int J Urol; 2003 Mar; 10(3):167-73. PubMed ID: 12622714 [Abstract] [Full Text] [Related]
18. Acetylation genotype and phenotype in patients with systemic lupus erythematosus. Rychlik-Sych M, Skretkowicz J, Gawrońska-Szklarz B, Górnik W, Sysa-Jedrzejowska A, Skretkowicz-Szarmach K. Pharmacol Rep; 2006 Mar; 58(1):22-9. PubMed ID: 16531626 [Abstract] [Full Text] [Related]
19. N-acetyltransferase-2 genotypes among patients with rheumatoid arthritis attending Jordan University Hospital. Oqal MK, Mustafa KN, Irshaid YM. Genet Test Mol Biomarkers; 2012 Sep; 16(9):1007-10. PubMed ID: 22731637 [Abstract] [Full Text] [Related]